
Crystal D’Silva
Associate Director – Preclinical Toxicology

Crystal D’Silva is a Preclinical subject matter expert at Baxter International and based in Brussels, Belgium. She is actively involved in standard development as a national expert in the ISO/TC 194 Biological and Clinical Evaluation of Medical Devices technical committee and she is part of several working groups within Medicines for Europe, MedTech Europe, and the International Generic and Biosimilars Association. She is also a European Registered Toxicologist (ERT) and a Diplomate of the American Board of Toxicology (DABT). She has a PhD in Medical Biophysics from the University of Toronto in collaboration with the Princess Margaret Cancer Centre and the Hospital for Sick Children (Ontario, Canada).
DAY 1: December 4th, 2025
SESSION: Toxicological Risk Assessment of N-Nitrosamines: Challenges and Perspectives
◆ Overview of toxicological risk assessment of nitrosamines.
◆ Comparison between agency- and literature-published acceptable intake values.
◆ Challenges with the current state of affairs and future perspectives.
◆ Weight-of-evidence approach in setting acceptable intake limits – NDBzA as a case study.
DAY 1: December 4th, 2024
SESSION: Toxicological Risk Assessment of Nitrosamines – Challenges and Perspectives
◆ Overview of toxicological risk assessment of nitrosamines.
◆ Comparison between agency- and literature-published acceptable intake values.
◆ Challenges with the current state of affairs and future perspectives.






